arrow
A

Alice L. Rodriguez

Vanderbilt University School of Medicine
H指数:36
被引数:4,135

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of VU6077564: A Selective M1 Antagonist That Promotes Neurite Outgrowth in Adult Sensory Neurons

发现VU6077564:一种选择性M1拮抗剂,可促进成年感觉神经元轴突生长

2026-07-070
OA
Discovery of VU6066098: A Selective and CNS-Penetrant mGlu2 NAM with Robust Antidepressant-; Antipsychotic-; and Procognitive-like Activity in Rodents

发现VU6066098:一种选择性中枢神经系统可穿透的mGlu2 NAM,在啮齿动物中表现出强效的抗抑郁、抗精神病和促认知样活性

2026-06-230
OA
Drug Repurposing: Conversion of the Peripherally Restricted HIV Protease Inhibitor Amprenavir to Potent; Selective; and CNS-Penetrant Agonists for the Cannabinoid Receptor 2
2026-02-050
OA
Discovery of VU6025733 (AG06827): A Highly Selective; Orally Bioavailable; and Structurally Distinct M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust In Vivo Efficacy
2026-01-250
OAAI
Discovery of 7-(Pyridin-3-yl)thieno[3; 2-b]pyridine-5-carboxamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5
2026-01-250
OAAI
Characterization of Novel and Known Activators of Cannabinoid Receptor Subtype 2 Reveals Mixed Pharmacology That Differentiates Mycophenolate Mofetil and GW-842,166X from MDA7

新型和已知大麻素受体2型亚型激活剂的表征揭示了一种混合药理学,该药理学区分了霉酚酸吗啉酯和GW-842,166X与MDA7。

2025-05-210
OA
Discovery of Thieno[3,2-b]pyridine-5-carboxamide and 2,3-Difluorobenzamide Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5
2025-04-010
OAAI
Discovery of VU0467319: an M1 Positive Allosteric Modulator Candidate That Advanced into Clinical Trials
2024-12-110
OAAI
Discovery of 4-(5-Membered)Heteroarylether-6-methylpicolinamide Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5
2024-11-180
OAAI
Discovery of VU6016235: A Highly Selective, Orally Bioavailable, and Structurally Distinct Tricyclic M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM)
2024-09-240
OAAI
Discovery of VU6007496: Challenges in the Development of an M1 Positive Allosteric Modulator Backup Candidate
2024-08-282
OAAI
Development of VU6036864: A Triazolopyridine-Based High-Quality Antagonist Tool Compound of the M5 Muscarinic Acetylcholine Receptor
2024-08-060
OAAI